Related Experiment Video
Updated: Jan 4, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis
Travis Frantz1, Ellen G Wright1, Esther A Balogh1
1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.
Insights
Treating pediatric atopic dermatitis and psoriasis is challenging due to limited approved options. This review offers guidance on available topical and oral treatments, including off-label uses, for these conditions in children.
Area of Science:
- Pediatric Dermatology
- Dermatological Therapeutics
Background:
- Pediatric atopic dermatitis and psoriasis management is hindered by a lack of standardized guidelines and FDA-approved treatments.
- Adult treatments are often used off-label in pediatric populations.
Purpose of the Study:
- To review available topical and oral treatment options for pediatric atopic dermatitis and psoriasis.
- To provide a basic therapeutic guideline, including off-label considerations.
Main Methods:
- A PubMed literature search was conducted.
- Focused on topical and systemic treatments for pediatric psoriasis and atopic dermatitis.
- Information gathered included age appropriateness, efficacy, dosing, contraindications, adverse events, and off-label usage.
Main Results:
- Seven topical and five systemic treatments are commonly used for pediatric atopic dermatitis and psoriasis.
- Data on age, efficacy, dosing, contraindications, and adverse events were compiled.
Conclusions:
- Standardized guidelines for treatment selection, dosing, and long-term safety in pediatric patients are scarce.
- Current pediatric treatment approaches rely heavily on clinical experience and expert recommendations due to limited official approvals.
Background:
Treatment of atopic dermatitis and psoriasis in children is difficult due to lack of standardized treatment guidelines and few FDA-approved treatment options. Treatments approved for adults may be used off-label in pediatric patients.
Objective:
This review evaluates the topical and oral treatment options available, including off-label uses, and provides a basic therapeutic guideline for pediatric atopic dermatitis and psoriasis.
Methods:
A PubMed review of topical and systemic treatments for pediatric psoriasis and atopic dermatitis with information regarding age, efficacy, dosing, contra-indications, adverse events, and off-label treatments.
Results:
The search identified seven topical and five systemic treatments that are routinely employed to treat pediatric atopic dermatitis and psoriasis.
Limitations:
Standardized guidelines regarding treatment choice, dosing, and long-term safety are scarce. Reviews may be subject to ascertainment bias.
Conclusions:
Current treatment guidelines are based on clinical experience and expert advice with few treatments officially approved for atopic dermatitis and psoriasis in children.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drug Therapy
Antianxiety Medications
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

